A Multicenter, Randomized, Phase 2a Study of Human Monoclonal Antibody to IL-12p40 (CNTO 1275) in Subjects With Moderately to Severely Active Crohn's Disease
收藏DataCite Commons2024-12-04 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/00004692/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to examine the safety and efficacy of CNTO 1275 in participants with active Crohn's Disease.
提供机构：
Vivli
创建时间：
2019-09-19
